We are live on !
Find out more
Cliff Asness AQR Capital Management
AUM
$287B
Turnover
8.35%
1-Year Est. Return
42.33%
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
This Fund
S&P 500
This Quarter Est. Return
+22.95%
1 Year Est. Return
+42.33%
3 Year Est. Return
+119.89%
5 Year Est. Return
+147.33%
10 Year Est. Return
+543.74%
AUM
$287B
AUM Growth
+$68.5B
(+31%)
Cap. Flow
+$37.5B
Cap. Flow % of AUM
Cap. Flow %
13.08%
Top 10 Holdings %
Top 10 Hldgs %
12.15%
Holding
3,986
New
247
Increased
2,455
Reduced
1,098
Closed
86
Avg Time Held
4.1
years
Top 10 Avg Time Held
3.3
years
Top 20 Avg Time Held
2.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.17B |
| 2 |
Apple
AAPL
|
+$849M |
| 3 |
Chevron
CVX
|
+$746M |
| 4 |
Synopsys
SNPS
|
+$643M |
| 5 |
Wells Fargo
WFC
|
+$633M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$517M |
| 2 |
Booking.com
BKNG
|
+$488M |
| 3 |
Walmart Inc
WMT
|
+$414M |
| 4 |
Sandisk
SNDK
|
+$355M |
| 5 |
Cigna
CI
|
+$325M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.5% |
| 2 | Financials | 14.38% |
| 3 | Industrials | 14.2% |
| 4 | Consumer Discretionary | 10.53% |
| 5 | Healthcare | 10.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2451
Adamas Trust
ADAM
$591M
| $2.59M | ﹤0.01% |
275,924
+50,611
| +22% | +$435K |
2024 Q2
8 quarters
|
|
2452
Arcus Biosciences
RCUS
$2.32B
| $2.59M | ﹤0.01% |
83,861
-2,433
| -3% | -$60.1K |
2023 Q4
10 quarters
|
|
2453
Valaris
VAL
$7.31B
| $2.58M | ﹤0.01% |
35,605
-43,225
| -55% | -$4.02M |
2022 Q3
15 quarters
|
|
2454
Gorman-Rupp
GRC
$1.9B
| $2.58M | ﹤0.01% |
28,155
-7,076
| -20% | -$538K |
2018 Q2
32 quarters
|
|
2455
DELISTED
Nuvalent
NUVL
| $2.58M | ﹤0.01% |
20,880
-5,951
| -22% | -$640K |
2023 Q2
12 quarters
|
|
2456
TriMas Corp
TRS
$1.37B
| $2.58M | ﹤0.01% |
57,244
+22,847
| +66% | +$909K |
2025 Q3
3 quarters
|
|
2457
U-Haul Holding Co Series N
UHAL.B
$9.9B
| $2.57M | ﹤0.01% |
44,607
+753
| +2% | +$37.5K |
2022 Q4
14 quarters
|
|
2458
Gossamer Bio
GOSS
$63.5M
| $2.57M | ﹤0.01% |
195,375
+68,789
| +54% | +$1.54M |
2025 Q3
3 quarters
|
|
2459
Vanguard Utilities ETF
VPU
$8.43B
| $2.57M | ﹤0.01% |
+13,138
| New | +$2.58M |
2026 Q2
0 quarters
|
|
2460
LifeMD
LFMD
$111M
| $2.56M | ﹤0.01% |
619,506
+421,184
| +212% | +$1.86M |
2024 Q3
7 quarters
|
|
2461
Clover Health Investments
CLOV
$2.37B
| $2.56M | ﹤0.01% |
488,182
+382,993
| +364% | +$1.3M |
2025 Q1
5 quarters
|
|
2462
BancFirst
BANF
$3.71B
| $2.55M | ﹤0.01% |
22,938
+9,190
| +67% | +$1.03M |
2024 Q2
8 quarters
|
|
2463
CSW Industrials
CSW
$4.66B
| $2.55M | ﹤0.01% |
9,151
+2,374
| +35% | +$659K |
2017 Q4
34 quarters
|
|
2464
Installed Building Products
IBP
$5.67B
| $2.55M | ﹤0.01% |
11,079
+233
| +2% | +$56.6K |
2023 Q1
13 quarters
|
|
2465
BlackLine
BL
$1.97B
| $2.54M | ﹤0.01% |
90,600
+22,074
| +32% | +$660K |
2025 Q3
3 quarters
|
|
2466
PJT Partners
PJT
$3.83B
| $2.54M | ﹤0.01% |
16,816
-3,403
| -17% | -$524K |
2020 Q2
24 quarters
|
|
2467
Valvoline
VVV
$4.12B
| $2.54M | ﹤0.01% |
64,792
+32,224
| +99% | +$1.12M |
2024 Q4
6 quarters
|
|
2468
IDEAYA Biosciences
IDYA
$3.08B
| $2.53M | ﹤0.01% |
67,976
+25,813
| +61% | +$790K |
2025 Q2
4 quarters
|
|
2469
Array Technologies
ARRY
$522M
| $2.52M | ﹤0.01% |
340,466
+70,314
| +26% | +$560K |
2022 Q3
15 quarters
|
|
2470
Camtek
CAMT
$5.45B
| $2.52M | ﹤0.01% |
15,940
+9,037
| +131% | +$1.6M |
2026 Q1
1 quarter
|
|
2471
Republic Bancorp
RBCAA
$1.77B
| $2.51M | ﹤0.01% |
27,808
+5,778
| +26% | +$458K |
2024 Q3
7 quarters
|
|
2472
BrightSpire Capital
BRSP
$426M
| $2.51M | ﹤0.01% |
460,473
-13,989
| -3% | -$80.2K |
2025 Q1
5 quarters
|
|
2473
Medifast
MED
$136M
| $2.51M | ﹤0.01% |
236,434
+90,859
| +62% | +$1.05M |
2020 Q2
24 quarters
|
|
|
ACA
2474
DELISTED
Arcosa
ACA
| $2.5M | ﹤0.01% |
17,235
+1,595
| +10% | +$198K |
2018 Q4
30 quarters
|
|
2475
Five Star Bancorp
FSBC
$1.1B
| $2.5M | ﹤0.01% |
51,305
+9,057
| +21% | +$382K |
2025 Q2
4 quarters
|
|
Similar funds
Cliff Asness's Q2 2026 Portfolio in Review
As of Q2 2026, Cliff Asness held 3,986 positions worth $287B, up 31% from $218B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Cliff Asness deployed $37.5B of net new capital in Q2 2026, opening 247 new positions and adding to 2,455 existing holdings. Its largest new stake was FedEx Freight: 1,024,555 shares worth $155M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Micron Technology, an estimated $517M trimmed.
- Cliff Asness's largest Q2 2026 buy was FedEx Freight: 1,024,555 shares worth $155M.
- Cliff Asness added most to NVIDIA in Q2 2026, an estimated $1.17B increase.
- Cliff Asness's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $517M.
- Cliff Asness fully exited Masimo in Q2 2026, selling an estimated $147M.
- Cliff Asness's ten largest holdings make up 12% of its $287B portfolio in Q2 2026.
- Cliff Asness opened 247 new positions and closed 86 in Q2 2026.
- Cliff Asness's portfolio value rose 31% quarter-over-quarter to $287B.
Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.